PNV 9.28% $2.59 polynovo limited

Addressable Market

  1. 224 Posts.
    lightbulb Created with Sketch. 36
    Hey,
    Just trying to do some more research and after some help from others that may have already done similar research.

    I am trying to work out what i think the total addressable market is for Novosorb alone (ignoring Hernia/Breast Products for now)

    at the moment I am looking at it like this and would love some thoughts and guidance who anyone who looks at this sort of stuff regularly if i am going about this sort of thing the right way.


    Burns Addressable Market
    As per the link below burns market is USD 2 billion in 2019 at 6.9% CAGR putting it at roughly 3 billion by 2025.
    now my attempt at a conservative assumption is that Novosorb might be usable in 1/3 of this so i am assuming a $1billion addressable market.

    https://www.grandviewresearch.com/industry-analysis/burn-care-market


    Diabetic Ulcer Addressable Market
    Now this is a huge market but i see Novosorb being applicable to a smaller number of cases than this total market size.
    as per below link the predicted diabetic ulcer market by 2025 is 6.82billion.

    so my attempt at a conservative assumption here is Novosorb might be applicable in 10% of this total in 2025, so roughly 700million.

    https://www.grandviewresearch.com/press-release/global-diabetic-foot-ulcer-dfu-treatment-market


    Conservative Total addressable market of Novosorb in 2025 roughly 1.7 Billion.(ignoring any R&D or hernia,breast,Drug eluting polymers ect)

    So my next attempt at a conservative assumption is to say maybe PNV only get 20-40% of my assumed burns market
    So (200-400million) and lets say they only get 10-20 % of my assumed diabetic market (70-150million million)

    So from working that out.

    270million to 650million revenue by 2025 on a product that has very high gross margin of 90% was it?
    so trying to be conservative again, after all costs i am going to assume that 50% of sales is costs.

    that puts EBITDA at 135m-325m per year (without any other products such as briefly mentioned above)

    now this seems ridiculous but did the management say they expect this to only account for 10% of sales in future? or was that just burns??

    anyway one more assumption. lets assume it makes up 50% of their revenue by 2025.

    so roughly and with some shoddy maths thats put boards expectations by 2025 at something like 270 million to 650 million earning???



    I HOPE this made sense to some people and was not to weird to follow, this is the first time i have tried to look at a company in this way and would appreciate any feedback or things that i am missing when trying to look at a company in this way...

    I am aware that the biggest factor here is my assumptions which is a dangerous thing obviously but has anyone else done something similar?

    Feedback welcome please.



 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.59
Change
0.220(9.28%)
Mkt cap ! $1.787B
Open High Low Value Volume
$2.44 $2.62 $2.44 $11.81M 4.632M

Buyers (Bids)

No. Vol. Price($)
5 8020 $2.58
 

Sellers (Offers)

Price($) Vol. No.
$2.59 48292 7
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.